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AbsTrACT
Drones are increasingly being used globally for the support 
of healthcare programmes. Madagascar, Malawi and 
Senegal are among a group of early adopters piloting the 
use of bi-directional transport drones for health systems in 
sub-Saharan Africa. This article presents the experiences 
as well as the strengths, weaknesses, opportunities and 
threats (SWOT analysis) of these country projects. Methods 
for addressing regulatory, feasibility, acceptability, and 
monitoring and evaluation issues are presented to guide 
future implementations. Main recommendations for 
governments, implementers, drone providers and funders 
include (1) developing more reliable technologies, (2) 
thorough vetting of drone providers’ capabilities during the 
selection process, (3) using and strengthening local capacity, 
(4) building in-country markets and businesses to maintain 
drone operations locally, (5) coordinating efforts among all 
stakeholders under government leadership, (6) implementing 
and identifying funding for long-term projects beyond pilots, 
and (7) evaluating impacts via standardised indicators. 
Sharing experiences and evidence from ongoing projects is 
needed to advance the use of drones for healthcare.
InTroduCTIon
Conventional health system strengthening 
approaches to enhance coverage of quality 
healthcare, such as capacity building, increased 
availability of commodities, improved infra-
structure and adequate health financing, 
develop gradually.1 They will, in the short to 
medium term, have a limited effect on the 
health outcomes of hard-to-reach populations 
in remote areas of sub-Saharan Africa. New 
technologies have the potential to accelerate 
access to healthcare, commodities and data for 
beneficiaries, providers and policy-makers.
Unmanned aerial vehicles, or drones, are 
one example of technology that can have 
a multitude of public health applications 
including supply chain support (eg, transport 
of medications, vaccines, biological samples), 
emergency response (eg, transport of blood 
and plasma), disease prevention (eg, sterile 
mosquito release for vector control), deploy-
ment of networks for data harvesting in uncon-
nected areas, and health research.2–9 In order 
to meet different needs, drones are available in 
various sizes, payload capacities, flight ranges, 
energy sources, propulsion systems, take-off/
recovery methods, cargo delivery configura-
tions, automation levels and costs.5
In 2014, for the first time, Médecins Sans 
Frontières demonstrated the potential of 
drones in healthcare by transporting sputum 
samples for tuberculosis (TB) diagnosis in 
Papua New Guinea.10 11 Since then, drone-based 
healthcare projects have emerged worldwide 
for a wide array of use cases. This emergence 
is especially visible in sub-Saharan Africa. 
The most prominent example is the drone 
project initiated in 2016 by the Government of 
Rwanda for transportation of sachets of blood 
summary box
 ► Bi-directional transport drone technology is currently 
being explored and advanced in order to make it fit 
for real-world applications.
 ► First-hand experiences from pioneer projects with 
regards to regulations, stakeholder collaboration, 
feasibility, data collection and local acceptability 
provide foundational building blocks for other drone 
initiatives.
 ► Continued, longer-term investments and implemen-
tation are required to soundly assess the technolo-
gy’s impact.
 ► Sustainable integration of drones into health sys-
tems needs in-country capacities, markets and 
businesses to locally own and operate a drone-sup-
ported system.
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to peripheral health centres.12 This project has mastered 
one-way air-drop delivery and is the only fully operational 
project in sub-Saharan Africa as of February 2019. However, 
there are a number of pilot and proof-of-concept projects 
in other countries exploring bi-directional transport, that 
is, the ability to land in a remote health facility or a village 
and return.
In this relatively new field of bi-directional drone delivery, 
literature is scarce and mostly restricted to theoretical 
documentation, roadmaps, market landscape and use-case 
analyses.13–17 Due to the early stage of implementation and 
limited small-scale pilot projects, little real-world experi-
ence and primary data related to drone technology perfor-
mance, operations, health impact, cost or acceptability 
are available to date.15 18–23 Lessons learnt from sub-Sa-
haran African pioneer drone projects represent the best 
available information from which to build on for future 
implementation.
In this article, we describe the regulatory, technical 
and operational aspects of the existing projects in Mada-
gascar, Malawi and Senegal. The authors directly involved 
in the conceptualisation and implementation of the proj-
ects performed a SWOT analysis (strengths, weaknesses, 
opportunities and threats). Finally, we draw conclusions 
from common and differing experiences and lessons 
learnt from across the countries and provide guidance 
for governments, implementers, drone providers and 
funders for future healthcare drone projects in the 
African region and beyond.
THe CAse of MAdAgAsCAr
Between 2016 and 2018, the ‘DrOTS: Drones Observed 
Therapy System in Remote Madagascar’ project was a 
proof-of-concept with a strong research component imple-
mented by Stony Brook University (New York, USA) and 
the Pasteur Institute of Madagascar. The project combined 
a bundle of technologies (including drones, digital adher-
ence monitors, cough counters and educational videos) in 
an innovative approach to forwardly deploy healthcare in 
remote settings.24 Drone technology was explored as a way 
of removing logistical barriers to quality TB care by flying 
sputum samples and medication for diagnosis and treat-
ment between a centralised, well-equipped laboratory and 
remote villages in one district (table 1 and online supple-
mentary file 1).25 The technology requirement was a drone 
with a high degree of autonomy (ie, no manual piloting) 
that did not require a runway, launcher or other heavy infra-
structure and that could perform bi-directional transport 
of goods for a 120 km flight range with a payload of up to 1 
kg. The project experienced three major obstacles: (1) the 
lack of drone-specific flight regulations led to delayed flight 
permit approval and required frequent renewals thereof; 
(2) the necessity of switching the drone technology early 
in the implementation phase due to the provider’s inability 
to deliver functional drones; (3) the subsequent unavail-
ability of a technology solution designed for the specific 
use case in real-world conditions of remote Madagascar 
(table 2). Consequently, a significant amount of resources 
were allocated to administrative procedures, product re-en-
gineering and in-house software development of new tech-
nology leading to implementation delays.
Although drones were not fully integrated into the 
local health system, proof-of-concept was achieved with 
drones successfully transporting dummy payloads. This 
project attracted the attention of the Malagasy govern-
ment, major health service providers and respective 
funders, who plan to integrate drones into their health 
provision activities in Madagascar.
THe CAse of MAlAwI
In the Malawian health sector, two bi-directional drone 
transport projects are dealing comprehensively with 
an array of regulatory and operational issues. In 2016, 
Unicef Malawi, in partnership with VillageReach, imple-
mented a feasibility study on the use of drones to facil-
itate the transport of dry blood spots for early infant 
diagnosis of HIV in two rural districts (table 1 and online 
supplementary file 1). VillageReach conducted an associ-
ated costing study in which drone costs were compared 
with the standard method of transporting samples via 
motorcycle.14 The study found that cost per kilometer is 
higher for drones compared to motorcycles. However, 
technology cost is expected to decrease and impor-
tantly, cost-effectiveness was not analysed. With support 
from Unicef, the Malawi Department of Civil Aviation 
embarked on a process of strengthening regulators’ insti-
tutional capacity, resulting in the issuance of an Aero-
nautical Information Circular on drones and draft drone 
regulations which are currently being finalised by the 
Ministry of Justice.26 In 2018, Unicef commissioned an 
assessment of the sample referral transportation network 
and health supply chain in two districts with hard-to-
reach facilities that modelled the benefits of integrating 
drones into an optimised specimen referral system.27 The 
study found that the benefits included increased equity 
and access for patients, responsiveness to urgent needs 
and potential use in emergencies and catastrophes. 
Based on these results, the Ministry of Health (MOH) is 
moving forward with integration of drones in the health 
system in the two districts. In 2018, VillageReach began 
conducting a study to assess the acceptability, feasibility, 
non-inferiority of sample quality, costs and benefits, and 
possibility of building a business case for the use of drones 
to transport blood and injectable oxytocin for obstetrical 
emergencies.22 23 However, test flights had to be stopped 
due to GPS interference from cellular towers. Neverthe-
less, VillageReach and the MOH used the information 
gained to develop an extensive community mobilisation 
strategy.23 The collaborative efforts of Unicef, Villag-
eReach and other stakeholders in Malawi have addressed 
initial regulatory, technical, operational and popula-
tion-based hurdles (figure 1). Remaining technical and 
operational challenges are being addressed in ongoing 
projects in collaboration with the MOH.
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Table 1 Characteristics and description of drone projects in Madagascar, Malawi and Senegal
Madagascar Malawi Senegal
Project name DrOTS: Drones Observed 
Therapy System in Remote 
Madagascar
1. Specimen referral and health 
supply chain optimisation using 
drones
2. Medical commodity delivery for 
preventable maternal deaths 
using drones
Drones for health supply 
payload delivery in 
Foundiougne district, Fatick 
region, Senegal
Project onset and end Nov 2017—Dec 2018 1. Mar 2016—ongoing
2. Dec 2017—ongoing
Dec 2017—ongoing
First flight May 2018 1. Mar 2016
2. Apr 2018
Jan 2018 (demonstration flights 
for regulatory authority)
Implementer(s) Stony Brook University, 
Pasteur Institute of 
Madagascar
1. Unicef
2. VillageReach
Ministry of Health, PATH
Partner(s) National Tuberculosis Control 
Programme,
Ministry of Public Health
1. Ministry of Health, Department of 
Civil Aviation, VillageReach
2. Ministry of Health, Malawi Blood 
Transfusion Services, Malawi 
Pharmacy, Medicines Poisons 
Board
Medical Region of 
Fatick, Medical District of 
Foundiougne, Pharmacie 
Nationale de Provissionnement, 
Pharmacie Regionale de 
Provissionnement, Fatick 
Region
Sponsor(s)/funder(s) TB REACH of the Stop TB 
Partnership
1. Unicef (feasibility); Unicef and 
USAID (implementation)
2. Grand Challenges Canada 
and Silicon Valley Community 
Foundation
The Bill & Melinda Gates 
Foundation
Drone type(s) Hybrid (fixed wing and 
quadcopter)
1. Quadcopter (feasibility); hybrid 
(implementation)
2. Hybrid (fixed wing and 
quadcopter)
Hybrid (fixed wing and 
quadcopter)
Manufacturer(s) Vayu (test flight); Vertical 
Technology Delta Quad 
(implementation)
1. Matternet (feasibility); Wingcopter 
(implementation)
2. Vayu (test flight); NextWing 
(implementation)
Vayu (test flight); to be 
confirmed for implementation
Drone operational 
service provider(s)
None 1. Matternet (feasibility); Wingcopter 
(implementation)
2. NextWing (implementation)
General Global Services 
(provisional)
No of drones 2 1.  To be determined
2.  1 in use, 2 planned
To be determined
Maximum flight range 60 km 1. 100 km
2. 80 km
60 km
Maximum payload 1.5 kg 1.  6 kg depending on distance
2.  2.2 kg (test flight), 1 kg 
(implementation)
2 kg
Propulsion system Electric 1.  Electric
2.  Electric
Electric
Flight control Autonomous but monitored 1.+2. Autonomous but monitored Autonomous but monitored
Purpose Sputum and medication 
transport for diagnosis and 
treatment of tuberculosis
1. Collection of medical samples 
(TB and HIV diagnosis, viral load) 
and delivery of medication
2. Blood and injectable oxytocin 
transport for maternal health 
emergencies
Delivery of urgent essential 
drugs and collection of medical 
samples
Continued
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Madagascar Malawi Senegal
Destination(s) A. Peripheral health centre
B. Villages
1. +2.
A. District hospitals
B. Peripheral health centres
C. Blood testing sites
A. District health centre (drone 
base)
B. 3–4 health posts in the dis-
trict (islands)
C. Regional hospital
D. Regional pharmacy
System approach Bi-directional transport/
delivery between (A) and (B) 
with landing in both
1.+2. Bi-directional transport/
delivery with landing in (A), (B) and 
(C)
Bi-directional transport/delivery 
between (A) and destinations 
(B), (C) and (D) with landing in 
all sites
Geographical scale, 
including health 
infrastructure
One district (1 health centre, 1 
health post), including villages
1. 2 districts, including islands
2. 2 districts (one central blood 
bank, 1 urban health centre, 1 
rural district hospital)
One district, including islands (4 
health posts)
Human resources Drone technicians, health 
personnel at (A), community 
health worker in (B)
1.+2. Drone technicians, health 
personnel, study team (core and 
partner organisations), ambulance 
crew (2. only) and police officers on 
standby
Drone technician and health 
personnel at (A), health 
personnel at (B), (C) and (D)
Total flights (until Dec 
2018)
Six flights (Vayu), 37 flights 
(Vertical Technologies)
1. 93 flights
2. One test flight
One test flight
Total deliveries made 
(until Dec 2018)
Six round flights (between 
10 and 42 km) using dummy 
payloads
1. None
2. Not applicable
Not applicable
Status of national 
regulations
Developed in 2017, pending 
final approval
Aviation circular developed in 2017, 
pending final approval
Regulations published26
Table 1 Continued
THe CAse of senegAl
In Senegal, since late 2017, the government, in collabora-
tion with PATH, is assessing the usefulness, health impact 
and cost-effectiveness of drones within the health supply 
chain system (table 1 and online supplementary file 1). 
The project is being implemented in a region where health 
facilities are isolated by island geography. Three use cases 
are being evaluated: (1) transporting laboratory samples for 
diagnostic tests, (2) delivering treatment for medical emer-
gencies and (3) delivering essential medicines and medical 
supplies when needed between routine supply trips.
Since the onset, regulatory authorities and govern-
mental stakeholders are engaged, a specific regulatory 
pathway is defined, an evaluation protocol is drafted, 
and stakeholders at district level are active participants. 
Standard operating procedures were established to guide 
operations, starting from the moment a need for a drone 
transport is identified until the flight is completed. One 
main challenge was the overestimation of the technical 
readiness of the initial drone provider to operate in the 
given setting. The provider was not able to successfully 
demonstrate autonomous flights between the base and 
designated destinations as well as a successful ‘return to 
home’ function. Another major challenge was finding 
freight carriers willing to handle the high-energy-den-
sity lithium polymer batteries for shipment to Dakar. 
The project is currently seeking additional resources to 
enable another drone provider to receive flight authori-
sation which will allow operations to begin.
TrACkIng And MeAsurIng IMpACT
As with any new intervention, decision-makers and 
investors need detailed and accurate information 
about the potential costs and benefits to the health 
system. To date, no consistent methodology for data 
collection for drone-based operations has been 
proposed or employed. Importantly, the implementa-
tion of drones might not always translate into imme-
diately identifiable health outcome changes but may 
be noticeable through surrogate endpoints, such 
as shorter delays in laboratory sample referrals or a 
reduction in medical supply stock-outs.28 Based on 
experiences from Madagascar, Malawi and Senegal, 
we propose a set of standardised indicators to monitor 
and evaluate the impact of future drone-supported 
healthcare programmes (table 3). This set of qualita-
tive and quantitative indicators should serve as guid-
ance for ongoing or future initiatives and pave the 
way to a harmonised approach to monitoring the use 
of bi-directional transport drones for health.
Triangulating data from the five categories presented 
(ie, health systems performance, process indica-
tors, costs, technical performance and acceptance) 
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Table 2 Strengths, weaknesses, opportunities and threats (SWOT) analysis of drone projects in Madagascar, Malawi and 
Senegal
Strengths Weaknesses
 ► Government support and engagement (eg, ministries of health, 
defence, transport, including civil aviation authorities) are 
indispensable to implementation
 ► National, multisectoral stakeholder committees are important to 
guide and coordinate activities and raise awareness
 ► Value of community engagement and acceptance efforts has been 
demonstrated
 ► Drone-specific flight regulations have been developed in all 
countries in reaction to the increased use of drones (with varying 
current implementation status)
 ► Competitive tendering for drone operator has resulted in 
identification of most suitable technology
 ► Local human resources, skills and institutional capacity-building 
efforts contribute to locally owned and operated projects
 ► Favourable operating environments (eg, testing corridor in Malawi) 
have facilitated testing of new technologies by different users
 ► Feasibility testing resulted in first successful bi-directional flights 
and dummy cargo transports
 ► Accompanying studies (eg, acceptability, health outcomes, 
cost-effectiveness analyses) increased the body of evidence and 
lessons learnt to guide future implementation
 ► Standard operating procedures for drone operations have been 
developed
 ► Parallel use cases in other sectors, eg, agriculture, conservation, 
disaster response, have increased interest, advocacy, ease 
of implementation and acceptance of drone use and created 
synergies
 ► High international visibility was achieved bringing attention to the 
use case
 ► Lengthy and delayed development of drone 
regulations
 ► Limited in-country technical capacity
 ► Lengthy and costly importation of technology and 
equipment into country
 ► Need for technology switch mid-projects (technical 
challenges and unavailability from operating 
provider)
 ► Limited readiness of technology in real-world 
settings (eg, GPS interference) leading to need 
for technology development on site (software and 
hardware)
 ► Difficulty sourcing funding for activities beyond 
proof-of-concept or small-scale implementation
 ► Lack of business cases in-country, partly due to 
lack of implementation beyond proof-of-concept
 ► Scarcity of data on, eg, performance, impact, 
acceptability, partly due to recent implementation
Opportunities Threats
 ► Political awareness and desire to work with drones is increasing
 ► Political interests are aligned with drone project objectives
 ► Positive feedback from communities on the potential use of 
drones for health
 ► African Drone and Data Academy will build local skills and 
entrepreneurship opportunities
 ► Supportive regulatory environment enables drone use in absence 
of final regulations
 ► Wealth of lessons learnt by the pioneer implementers of bi-
directional drone use encourage project continuation and guide 
new projects
 ► Drone testing corridor provides opportunities for different types of 
drones to be tested by different users
 ► Donor interest to fund existing and new projects
 ► Potential for cost-effectiveness compared with conventional 
transport
 ► Increasing number of use cases reaching more people in need of 
healthcare
 ► Occasional unreliability of currently available 
technology (hardware and software)
 ► Limited technical expertise and capacities in-
country leading to dependency on external/
international service providers
 ► Competing interests between in-country health 
stakeholders
 ► Sensitivity and potential dangers of delivery of blood 
or biological samples
 ► Unsecured funding to continue activities, potentially 
reversing health gains
 ► Local health sectors reliant on donor funding with 
limited ability to assume financial responsibility
will allow accurate measurements and evaluation 
of impacts of drones, including whether the use of 
drones improved efficiency and equity of service 
delivery, cost-effectiveness and health outcomes. 
Measuring these indicators will allow a comparison 
to (1) baseline before drone implementation and (2) 
non-drone-supported settings using traditional trans-
portation systems.
Indicators rely on quantitative and qualitative data 
sources, whereas certain indicators require subjective 
scales (eg, sample quality), estimations or average 
values. Since drone-specific data are not recorded 
in routine health or laboratory information systems, 
the authors propose the new umbrella term ‘drone 
information system (DIS)’ to cover all drone-related 
flight-log and telemetry data. Integrating certain DIS 
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Figure 1 Drone flying in Malawi (March 2016). Messinis/
Matternet.
information within the routine health information 
system is recommended. For example, ‘dispatched 
and received’ logs about payload should be linked to 
the existing stock registries in health facilities.
reCoMMendATIons And wAys forwArd
This work represents the first collection of hands-on 
experience on the use of bi-directional transport drones 
for healthcare in sub-Saharan Africa. Strengths, weak-
nesses, opportunities and threats across the projects are 
summarised in table 2. Commonalities and differences in 
scale, approaches and regulatory landscapes have influ-
enced successes and challenges of each individual drone 
project. Taken together, they have pioneered the use of 
bi-directional drones for health purposes on the African 
continent, provide early experiences for others to build 
on and encourage the continued use of aerial technology 
in healthcare provision.
for policy-makers/governments/ministries of health
For many countries, drone flight regulations were (or 
still are) new territory and regulatory agencies are faced 
with the challenge of guaranteeing safety and security of 
a new technology which may not have had prior commer-
cial applications in-country.29 Countries need to develop 
drone regulations that reflect international guidance 
(eg, from the International Civil Aviation Organization) 
and should consider lessons learnt in other countries. 
For example, Rwanda pioneered the ‘performance-based 
regulations’ model, designed to facilitate drone oper-
ators’ access to airspace through a mission-specific 
approach.30 Therein, regulatory agencies determine the 
safety requirements for the drone operator’s proposed 
mission, who, in turn, has to prove how it will meet them, 
no matter the technology used.31 This model achieves the 
balancing act between safety and allowing the use of new 
technology that would not have been approved if tradi-
tional, lengthy certification processes were applied.
Governments should also employ a system-strength-
ening approach to identify health system bottlenecks 
and explore new areas for supply chain optimisation and 
cost-effectiveness using drones. In the planning phase, the 
use case and technology requirements need to be defined 
using available tools, including but not restricted to the 
metrics displayed in table 1.32 The suitable technology 
solution responding to those needs should be provided 
by manufacturers, which might require new technology 
development. This process, although longer to start up 
and costlier initially, is recommended as opposed to 
relying on readily available but relatively unproven tech-
nologies. This approach was recently taken by Unicef 
Vanuatu and the World Bank Lake Victoria Challenge.33
Currently, resources and capacities to mount and main-
tain a functional drone system are varying across sub-Sa-
haran African countries. The technical base to draw from 
for fully locally operated drone systems is believed to be 
sufficient in certain countries. However, there is a limited 
number of local businesses created for this purpose. In 
countries where technical resources and human capac-
ities might be limited, an international drone service 
provider presents a valuable option, at least during an 
initial phase until local capacity is strengthened.11 While 
drone service providers can be costly and might not 
always be able to deliver the optimal solution for every 
setting, they come with technical skills, experience and 
are bound to deliverables. For sustainable in-country 
operations and maintenance, local capacity building is a 
critical factor and should be demanded by governments, 
facilitated by implementers and supported by funders. 
To this end, partnerships with local universities and 
schools of technology offer good opportunities to build 
local skills and entrepreneurship. For example, WeRo-
botics’ Flying Labs is an international network that works 
towards localisation of drone solutions through training 
and business incubation.34
Though lead implementing institutions varied across 
the presented projects—international organisations 
(Malawi and Senegal) or research institutions (Mada-
gascar)—all were implemented in partnership with the 
countries’ respective health ministries and local gover-
nance structures. Government institutions play a para-
mount role in facilitating project approval, negotiating 
with regulatory bodies and between ministries, and 
coordinating a country approach among all health stake-
holders even in cases where domestic funding cannot be 
provided. While implementers might be excited to use 
innovative technologies, governments are needed to 
‘steer the drone’ so that, with their leadership, drone-sup-
ported health systems can really take flight.
for implementers
After approximately 3 years of implementation of several 
proof-of-concept drone projects, the technology is still 
in its feasibility phase for many use cases. To this date, 
projects have yet to produce sufficient data to demon-
strate a direct or indirect impact on health outcomes. 
We acknowledge that in the context of rapid technology 
development and short project lifespans, the collection 
and sharing of performance data has not automatically 
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been a priority. However, in light of the increasing 
country demand for health-related drone projects, it is 
important that implementers share their data in a timely 
manner. To properly assess the long-term feasibility and 
impacts of the use of drones, the indicators listed in 
table 3 may serve as a minimum guidance for ongoing or 
future drone projects.
Data will further allow to assess the cost-effectiveness 
of drone use as compared with a standard of care. A 
2016 cost-effectiveness analysis study found that drones 
can increase vaccine availability and decrease costs as 
compared with standard of care, if drone use was maxi-
mised and optimised to overcome the initial invest-
ment and maintenance costs.13 However, this is the only 
modelled cost-effectiveness study currently available 
whereas real-life data are missing in the public sphere. 
Importantly, technology costs keep evolving but may 
be lowered once the technology enters a commercially 
developed stage. Stakeholders further agree that while 
cost-effectiveness is an important aspect to consider 
for countries and funders, cost is not the only or most 
important factor if lives can be saved.11 However, even 
if shown to be cost-effective, the willingness to pay for 
drone-supported systems is not guaranteed, especially 
considering that many countries already lack resources 
for health supply chain transport needs.35
Another important aspect to consider is the local accept-
ability of the drones, especially when deployed in popula-
tions with limited previous exposure to technologies. In 
Madagascar, an acceptability assessment conducted with 
community members found a large majority in favour 
of seeing drone technology being used for healthcare 
in their community. In Malawi, the acceptability compo-
nent was assessed through key stakeholder interviews on 
all levels and focus group discussions in communities.22 23 
In general, there was low awareness of drones but high 
acceptability once the idea of drones used for medical 
transport was introduced. Concerns circled around the 
safety of people and property, privacy and sustainability, 
while the main benefit was seen as potential transporta-
tion time saved. These studies underline the importance 
of implementing a comprehensive community mobilisa-
tion plan. This ideally includes the physical presentation 
of a drone (eg, to demystify it, show absence of a camera), 
comprehensive information on benefits and risks, and 
operational details (eg, flight paths, flight times, prod-
ucts flown).
In many countries, there will likely be different health-
care providers implementing their own drone projects 
in the future. While projects can be complementary, 
with one doing long-distance parachuting and the other 
short-distance bi-directional transport as an example, 
there is potential for parallel and competing projects. 
It is therefore important to coordinate efforts and not 
burden local health systems with competitive interests. 
Instead, joint operational or regulatory initiatives might 
reduce the burden for health ministries and regulatory 
agencies.
for drone manufacturers and providers
Three of the projects required changing the initial tech-
nology or provider (table 1). Challenges specific to these 
low-resource countries demonstrated that adjustments 
to the currently available technology were required. The 
technology needs to be functional in the most extreme 
contexts where, for example, the lack of power requires 
solar-powered systems, the lack of network connectivity 
needs alternative communication and tracking systems, 
the lack of technical knowledge needs user-friendly 
systems, or different weather conditions such as heat 
requires cargo containers to have integrated cooling 
systems. So far, bi-directional transport requires technical 
skills at both ends of the flight. An easy-to-use technology 
requiring minimal technical knowledge at least on one 
end (eg, with the community health worker) in combi-
nation with minimal but adequate training is needed to 
make the technology widely applicable. Hence, drone 
manufacturers and providers are immediately chal-
lenged to build robust technologies responding to those 
real-world needs.
Manufacturers could also scope technology solutions 
that may exist beyond the public health sphere. Drones 
used for non-humanitarian purposes might have perfor-
mance features that humanitarian drones still lack and 
which could support the advances needed for the public 
health field.
Based on our experience, several weeks are required 
initially for drone providers to be in-country to test and 
adjust technologies. The context-specific challenges 
faced by implementers operating in different countries, 
such as importation of equipment or cell phone tower 
interference issues, confirm the importance of allowing 
ample time for testing.
Since other transport conditions are unlikely to change 
rapidly in remote areas in sub-Saharan Africa, reliable 
drone technology makes a compelling business model if 
local needs can be met. This holds true for drone tech-
nology, repair parts and other associated equipment. 
For example, the shipment and importation of lithium 
polymer batteries posed a challenge in Madagascar and 
Senegal. The upsurge in private and commercial drone 
use presents a local business opportunity for importation 
of batteries and other drone parts, as well as recycling 
of some of these components for other purposes (eg, 
re-using drone batteries in solar energy systems).
for sponsors/funders
The projects presented here were all fully supported 
by foreign funding, although importantly, local minis-
tries contributed through provision of structures and 
personnel. Implementers of the projects presented here 
have been approached by major donors such as the Global 
Fund to Fight AIDS, Tuberculosis and Malaria, the Bill & 
Melinda Gates Foundation, and USAID enquiring about 
experiences and potential evidence. For developers, 
implementers and researchers alike, it would be helpful 
if funders were explicit about what evidence they need 
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(eg, cost-effectiveness, safety, acceptability, local sustaina-
bility) before deciding to fund.
At this stage, funders need to be aware that they invest 
in a technology still needing iterative development in real-
world contexts. Ample flexibility in funding is needed so 
that implementers can keep up with the rapid pace at 
which the technology is changing. In addition, compa-
rable with the phases of drug development trials, drone 
software and hardware development, impact evaluation 
and final implementation requires longer-term invest-
ment, with funds that go beyond pilot projects. The field 
may also seek investment from the private sector, invest-
ment funds or venture capital sources in order to more 
quickly reach the point of technical robustness needed.
ConClusIon
We conclude that drones are increasingly being tested 
for healthcare purposes around the globe. They can be 
understood as a tool complementary to existing transport 
systems offering advantages over traditional approaches 
in certain circumstances. How and where drones opti-
mally fit into health systems is still being determined 
and will depend on local needs and resources. Currently, 
projects attempting bi-directional drone transport are 
still exploring the possibilities, advancing the technolo-
gies and gathering real-world experiences.
The integration and optimisation of new technolo-
gies into health systems is a process over several years. 
As a recent example, mobile health (m-Health) solutions 
experienced a slow start in the 1990s.36 Its use increased 
rapidly in the wake of computer and communication 
networks and more recently smartphones, surpassing 
geographical, temporal and organisational barriers. In 
evolving technological and market environments, drones 
could take a similar trajectory. As with any innovative 
health intervention, the sustainability of drone-sup-
ported healthcare systems will further necessitate strong 
capacity building, an efficient impact monitoring and 
evaluation cycle and in-country commitment, including 
investment in drone regulations, project design and 
long-term ownership.
Our projects presented here were able to overcome 
challenges and demonstrate successes with regards to 
regulations, in-country collaborations, proof of feasi-
bility, information sharing and local acceptability. Based 
on the experiences gained to date, drones are worth 
future investments given their compelling prospect to 
support universal health coverage in sub-Saharan Africa 
and beyond.
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